Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of Wharton Jelly in Diabetic Nephropathy
NCT03288571Phase 2Unknown
- Start
- Nov 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of wharton's jelly mesenchymal stromal cells in diabetic nephropathy (DN). Status: unknown.
02
Drugs
wharton's jelly mesenchymal stromal cells
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03288571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288571.